Attention Deficit Hyperactivity Disorder among Clients Diagnosed with a Substance Use Disorder in the Therapeutic Communities: Prevalence and Psychiatric Comorbidity

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F21%3A10428007" target="_blank" >RIV/00216208:11110/21:10428007 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/21:10428007

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=CN~GidSkSt" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=CN~GidSkSt</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1159/000508571" target="_blank" >10.1159/000508571</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Attention Deficit Hyperactivity Disorder among Clients Diagnosed with a Substance Use Disorder in the Therapeutic Communities: Prevalence and Psychiatric Comorbidity

Popis výsledku v původním jazyce

Background: Most severe substance use disorders (SUDs) are connected with attention deficit hyperactivity disorder (ADHD) and other mental health problems. Therapeutic communities (TCs) provide a suitable option for the treatment of severe SUDs. The relationship between ADHD, the severity of the SUD, and other comorbidities in residential TCs is unknown. Objective: To estimate the prevalence of ADHD among clients with an SUD in residential rehab, and to compare the mental health of clients with and without ADHD. Methods: A cohort study was conducted in 5 residential TCs (N = 180, 76.7% male, 53.9% 25-34 years, 79.2% diagnosed with methamphetamine use disorder). We assessed ADHD symptoms, substance use, mental health problems, and psychiatric symptoms. Results: ADHD was found in 51% of the clients who showed significantly higher scores for their psychiatric status composite score (ASI-PSY) (F = 9.08, p &lt; 0.001; t = 5.05, p &lt; 0.001), the positive psychiatric symptoms total (SCL-PST) (F = 3.36, p &lt; 0.05; t = 3.15, p &lt; 0.01), and the global severity index (SCL-GSI) (F = 3.27, p &lt; 0.05; t = 3.18, p &lt; 0.01). The ASI-PSY and SCL correlated significantly with the symptoms of attention deficit disorder (Pearson&apos;s r&apos;s = 0.30-0.42, p&apos;s &lt; 0.001) and the symptoms of hyperactivity disorder (r&apos;s = 0.24-0.30, p&apos;s &lt; 0.01). Even when severity of substance use was accounted for, ADHD was confirmed as a significant predictor of ASI-PSY (B= 0.14, p &lt; 0.001 for combined disorder; B = 0.20, p &lt; 0.001 for attention disorder) and partially of SCL-PST (B = 8.12, p &lt; 0.05 for attention disorder). Conclusions: The ADHD prevalence in TCs was nearly 10-fold compared to the globally recorded values. ADHD diagnostic procedures and interventions should become an integral part of the standard diagnostic and treatment process.

Název v anglickém jazyce

Attention Deficit Hyperactivity Disorder among Clients Diagnosed with a Substance Use Disorder in the Therapeutic Communities: Prevalence and Psychiatric Comorbidity

Popis výsledku anglicky

Background: Most severe substance use disorders (SUDs) are connected with attention deficit hyperactivity disorder (ADHD) and other mental health problems. Therapeutic communities (TCs) provide a suitable option for the treatment of severe SUDs. The relationship between ADHD, the severity of the SUD, and other comorbidities in residential TCs is unknown. Objective: To estimate the prevalence of ADHD among clients with an SUD in residential rehab, and to compare the mental health of clients with and without ADHD. Methods: A cohort study was conducted in 5 residential TCs (N = 180, 76.7% male, 53.9% 25-34 years, 79.2% diagnosed with methamphetamine use disorder). We assessed ADHD symptoms, substance use, mental health problems, and psychiatric symptoms. Results: ADHD was found in 51% of the clients who showed significantly higher scores for their psychiatric status composite score (ASI-PSY) (F = 9.08, p &lt; 0.001; t = 5.05, p &lt; 0.001), the positive psychiatric symptoms total (SCL-PST) (F = 3.36, p &lt; 0.05; t = 3.15, p &lt; 0.01), and the global severity index (SCL-GSI) (F = 3.27, p &lt; 0.05; t = 3.18, p &lt; 0.01). The ASI-PSY and SCL correlated significantly with the symptoms of attention deficit disorder (Pearson&apos;s r&apos;s = 0.30-0.42, p&apos;s &lt; 0.001) and the symptoms of hyperactivity disorder (r&apos;s = 0.24-0.30, p&apos;s &lt; 0.01). Even when severity of substance use was accounted for, ADHD was confirmed as a significant predictor of ASI-PSY (B= 0.14, p &lt; 0.001 for combined disorder; B = 0.20, p &lt; 0.001 for attention disorder) and partially of SCL-PST (B = 8.12, p &lt; 0.05 for attention disorder). Conclusions: The ADHD prevalence in TCs was nearly 10-fold compared to the globally recorded values. ADHD diagnostic procedures and interventions should become an integral part of the standard diagnostic and treatment process.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30312 - Substance abuse

Projekt

<a href="/cs/project/GA14-07822S" target="_blank" >GA14-07822S: Vliv ADHD na vybrané psychické funkce, životní dovednosti a kvalitu života u klientů léčících se ze závislosti v terapeutických komunitách</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European Addiction Research

ISSN

1022-6877

e-ISSN

—

Svazek periodika

27

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

CH - Švýcarská konfederace

Počet stran výsledku

10

Strana od-do

87-96

Kód UT WoS článku

000630154700001

EID výsledku v databázi Scopus

2-s2.0-85090161394